Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol. 1928;4(4):285-292.7.

CAS  PubMed  PubMed Central  Google Scholar 

Lortholary P, et al. Chronic lymphoid leukemia secondarily associated with a malignant reticulopathy: Richter’s Syndrome. Nouv Rev Fr Hematol. 1964;4:621–44.

CAS  PubMed  Google Scholar 

Alaggio R, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Swerdlow SH, et al. The 2016 revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood. 2016;127(20):2375–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campo E, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229–53.

Article  CAS  PubMed  Google Scholar 

Bockorny B, Codreanu I, Dasanu CA. Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol. 2012;156(1):50–66.

Article  PubMed  Google Scholar 

Shao H, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24(11):1421–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakhachiro Z, et al. B-Lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases. Am J Clin Pathol. 2015;144(2):333–40.

Article  CAS  PubMed  Google Scholar 

Parikh SA, et al. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol. 2013;162(6):774–82.

Article  PubMed  PubMed Central  Google Scholar 

Parikh SA, Shanafelt TD. Risk factors for Richter syndrome in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2014;9(3):294–9.

Article  PubMed  Google Scholar 

Al-Sawaf O, et al. Richter transformation in chronic lymphocytic leukemia (CLL)–a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. 2021;35(1):169–76.

Article  CAS  PubMed  Google Scholar 

Tadmor T, Levy I. Richter transformation in chronic lymphocytic leukemia: update in the era of novel agents. Cancers. 2021;13(20):5141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrackova A, et al. Revisiting Richter transformation in the era of novel CLL agents. Blood Rev. 2021;49:100824.

Article  CAS  PubMed  Google Scholar 

Ibrutinib for relapsed/refractory chronic lymphocytic leukemia. a UK and Ireland analysis of outcomes in 315 patients. Haematologica. 2016;101(12):1563–72.

Article  Google Scholar 

Fraser G, et al. Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia. 2019;33(4):969–80.

Article  CAS  PubMed  Google Scholar 

Roberts AW, et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med. 2016;374(4):311–22.

Article  CAS  PubMed  Google Scholar 

Woyach JA, et al. Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med. 2018;379(26):2517–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn IE, et al. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood. 2017;129(11):1469–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharman JP, et al. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial. Lancet. 2020;395(10232):1278–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi D, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 2009;15(13):4415–22.

Article  CAS  PubMed  Google Scholar 

Zenz T, et al. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol. 2010;28(29):4473–9.

Article  PubMed  Google Scholar 

Gonzalez D, et al. Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol. 2011;29(16):2223–9.

Article  PubMed  Google Scholar 

Rossi D, et al. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. Br J Haematol. 2012;158(3):426–9.

Article  CAS  PubMed  Google Scholar 

Chigrinova E, et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013;122(15):2673–82.

Article  CAS  PubMed  Google Scholar 

De Paoli L, et al. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk Lymphoma. 2013;54(5):1087–90.

Article  PubMed  Google Scholar 

Klintman J, et al. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood. 2021;137(20):2800–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erin Michelle Parry, R.G., Ignaty Leshchiner, Daniel Rosebrock, Bria Persaud, Camilla K Lemvigh, Eugen Tausch, Matthew S. Davids, Johannes Bloehdorn, Christof Schneider, Liudmila Elagina, Aina Zurita Martinez, Amaro Taylor-Weiner, Nitin Jain, William G. Wierda, Laura Z. Rassenti, Thomas J. Kipps, Julien Broséus, Florence Cymbalista, Neil E. Kay, Kenneth J. Livak, Shuqiang Li, Teddy Huang, Noelia Purroy, Annabelle J Anandappa, Stacey M. Fernandes, Filippo Utro, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Kara Slowik, Sameer A. Parikh, Jennifer R Brown, Laxmi Parida, Donna S. Neuberg, Stephan Stilgenbauer, Gad Getz, Catherine J. Wu, Genetic determinants and evolutionary history of Richter’s syndrome, in American Society of Hematology Annual Meeting and Exposition. 2020: Virtual.

Parry EM, et al. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nat Med. 2023;29(1):158–69.

Article  CAS  PubMed  Google Scholar 

Broséus J, et al. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis. Nat Commun. 2023;14(1):309.

Article  PubMed  PubMed Central  Google Scholar 

Parry, E.M., E. Ten Hacken, and C.J. Wu, Richter syndrome: novel insights into the biology of transformation. Blood, 2023.

Wang Y, Ding W. Richter transformation of chronic lymphocytic leukemia in the era of novel agents. Clin Adv Hematol Oncol. 2020;18(6):348–57.

PubMed  Google Scholar 

Davids MS, et al. Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma. J Clin Oncol. 2017;35(8):826–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Visentin A, et al. The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation. Haematologica. 2022;107(4):868–76.

Article  PubMed  Google Scholar 

Miller CR, et al. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib. Blood Adv. 2017;1(19):1584–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kadri S, et al. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017;1(12):715–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maddocks KJ, et al. Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncol. 2015;1(1):80–7.

Article  PubMed  PubMed Central  Google Scholar 

Jain P, et al. Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood. 2015;125(13):2062–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanagal-Shamanna R, et al. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. Cancer. 2019;125(4):559–74.

Article  CAS  PubMed  Google Scholar 

Burger JA, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589.

Article  CAS  PubMed